A new era of treatments for microplastics is emerging. Here’s what to know.

Entrepreneurs aim to remove microplastics from the body, but the cost can be steep and the clinical benefit remains uncertain.
The Malaysian Reserve

Lilly’s Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...